Each and every biological function in living organism occurs due to protein-protein interactions. The
diseases are no exception to this. Identifying one or more proteins for a particular disease and then
designing a suitable chemical compound (which is known as drug or ligand) to destroy those proteins is a
challenging topic of research in computational biology. In earlier methods, drugs were designed using only
a few chemical components and were represented as a fixed-length tree. But in reality, a drug contains
many chemical groups collectively known as pharmacophore. Moreover, the chemical length of the drug
cannot be determined before designing that drug.
In the present work, a Particle Swarm Optimization (PSO) based methodology has been proposed to find
out a suitable drug for a particular disease so that the drug-target protein interaction energy becomes
minimum. In the proposed algorithm, the drug is represented as a variable length tree and essential
functional groups are arranged in different positions of that drug. Finally, the structure of the drug is
obtained and its docking energy is minimized simultaneously. Also, the orientation of chemical groups in
the drug is tested so that it can bind to a particular active site of a target protein and the drug fits well
inside the active site of target protein. Here, several inter-molecular forces have been considered for
accuracy of the docking energy. Results are demonstrated for three different target proteins both
numerically and pictorially. Results show that PSO performs better than the earlier methods.
Stable Drug Designing by Minimizing Drug Protein Interaction Energy Using PSO csandit
1. The document proposes using a particle swarm optimization (PSO) algorithm to design stable drug molecules that minimize interaction energy with target proteins.
2. In the algorithm, drugs are represented as variable-length trees containing functional groups, and PSO is used to optimize van der Waals and electrostatic interaction energies.
3. Results show that PSO performs better than previous fixed-length tree methods at designing drugs that stably bind to active sites of human rhinovirus, malaria, and HIV proteins.
Molecular docking involves binding a small ligand molecule to a larger target molecule to form a stable complex. Docking software simulates this binding process and calculates the energy of interactions between the ligand and target in different orientations. The best fitting ligand orientation is one that provides structural and chemical stability to the complex. Molecular docking and computer-aided drug design are used to identify chemical compounds that can interact with and inhibit or activate protein targets, with the goal of developing new drug candidates.
Molecular docking is a computational method that predicts the preferred orientation of one molecule to another when bound and forming a stable complex. It involves finding the best match between two molecules and can be used for drug design and development by predicting the binding affinity between potential drug candidates and their protein targets. Common molecular docking approaches include shape complementarity, which describes interacting molecules as complementary surfaces, and simulation methods, which simulate the actual docking process and calculate interaction energies between molecules. Popular molecular docking software includes AutoDock, FlexX, and GOLD.
This document discusses molecular docking, which is a computational method used in structure-based drug design to predict the preferred orientation of molecules when bound to their protein targets to form stable complexes. It begins by introducing drug discovery and computational chemistry approaches. It then defines molecular docking and describes different docking types and software. Applications of docking in modern drug discovery are presented, along with case studies and achievements that have resulted in new drug classes. The document concludes that docking contributes promisingly to drug discovery by aiding in target identification and lead optimization.
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS santosh Kumbhar
Molecular docking is a computational method used in structure-based drug design to predict how biological macromolecules interact with other molecules. It attempts to predict the preferred orientation of one molecule to another when bound to each other to form a stable complex. Docking is useful for predicting the binding orientation of small molecule drug candidates to their protein targets in order to predict their interaction and to design effective inhibitors. There are various types of docking software available that implement different algorithms to predict the binding orientation and affinity between molecules rapidly and accurately to help identify potential lead compounds for drug development. Molecular docking has contributed to the discovery of several new drug classes and is playing an increasingly important role in modern computer-aided drug design and virtual
Meta-docking is a Bayesian mixture model for improving protein-ligand interaction predictions from multiple docking scores. It accounts for differences in score distributions between active and decoy ligands arising from docking program and ligand effects. Compared to standard consensus docking, meta-docking shows small but consistent improvements in ranking ligands, detecting more active ligands among top ranks. Future work includes investigating inter-ligand features from multiple programs to further improve ligand ranking.
Docking is a computational method that predicts the preferred orientation of one molecule to another when bound to form a stable complex. It involves searching high-dimensional spaces to find the best matching between two molecules, such as a protein and ligand. Successful docking methods effectively search these spaces and use scoring functions to correctly rank candidate dockings in order to identify the correct ligand binding position and predict binding affinity.
A lecture on molecular docking that I give for master students at University Paris Diderot.
Warning: this presentation has numerous animations which are not included in the slideshare document.
https://florentbarbault.wordpress.com/
Stable Drug Designing by Minimizing Drug Protein Interaction Energy Using PSO csandit
1. The document proposes using a particle swarm optimization (PSO) algorithm to design stable drug molecules that minimize interaction energy with target proteins.
2. In the algorithm, drugs are represented as variable-length trees containing functional groups, and PSO is used to optimize van der Waals and electrostatic interaction energies.
3. Results show that PSO performs better than previous fixed-length tree methods at designing drugs that stably bind to active sites of human rhinovirus, malaria, and HIV proteins.
Molecular docking involves binding a small ligand molecule to a larger target molecule to form a stable complex. Docking software simulates this binding process and calculates the energy of interactions between the ligand and target in different orientations. The best fitting ligand orientation is one that provides structural and chemical stability to the complex. Molecular docking and computer-aided drug design are used to identify chemical compounds that can interact with and inhibit or activate protein targets, with the goal of developing new drug candidates.
Molecular docking is a computational method that predicts the preferred orientation of one molecule to another when bound and forming a stable complex. It involves finding the best match between two molecules and can be used for drug design and development by predicting the binding affinity between potential drug candidates and their protein targets. Common molecular docking approaches include shape complementarity, which describes interacting molecules as complementary surfaces, and simulation methods, which simulate the actual docking process and calculate interaction energies between molecules. Popular molecular docking software includes AutoDock, FlexX, and GOLD.
This document discusses molecular docking, which is a computational method used in structure-based drug design to predict the preferred orientation of molecules when bound to their protein targets to form stable complexes. It begins by introducing drug discovery and computational chemistry approaches. It then defines molecular docking and describes different docking types and software. Applications of docking in modern drug discovery are presented, along with case studies and achievements that have resulted in new drug classes. The document concludes that docking contributes promisingly to drug discovery by aiding in target identification and lead optimization.
MOLECULAR DOCKING AND RELATED DRUG DESIGN ACHIEVEMENTS santosh Kumbhar
Molecular docking is a computational method used in structure-based drug design to predict how biological macromolecules interact with other molecules. It attempts to predict the preferred orientation of one molecule to another when bound to each other to form a stable complex. Docking is useful for predicting the binding orientation of small molecule drug candidates to their protein targets in order to predict their interaction and to design effective inhibitors. There are various types of docking software available that implement different algorithms to predict the binding orientation and affinity between molecules rapidly and accurately to help identify potential lead compounds for drug development. Molecular docking has contributed to the discovery of several new drug classes and is playing an increasingly important role in modern computer-aided drug design and virtual
Meta-docking is a Bayesian mixture model for improving protein-ligand interaction predictions from multiple docking scores. It accounts for differences in score distributions between active and decoy ligands arising from docking program and ligand effects. Compared to standard consensus docking, meta-docking shows small but consistent improvements in ranking ligands, detecting more active ligands among top ranks. Future work includes investigating inter-ligand features from multiple programs to further improve ligand ranking.
Docking is a computational method that predicts the preferred orientation of one molecule to another when bound to form a stable complex. It involves searching high-dimensional spaces to find the best matching between two molecules, such as a protein and ligand. Successful docking methods effectively search these spaces and use scoring functions to correctly rank candidate dockings in order to identify the correct ligand binding position and predict binding affinity.
A lecture on molecular docking that I give for master students at University Paris Diderot.
Warning: this presentation has numerous animations which are not included in the slideshare document.
https://florentbarbault.wordpress.com/
In Silico methods for ADMET prediction of new moleculesMadhuraDatar
The document discusses the importance of predicting absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of new molecules in silico during drug design. It describes how ADMET prediction techniques have evolved since 1863 and helped advance drug development. Factors considered in developing ADMET prediction models include the model purpose, required prediction speed and accuracy. Common molecular descriptors used in these models are also discussed. The document outlines methods for predicting various ADMET properties like permeability, solubility, distribution and metabolism in silico. Recent tools for computational ADMET prediction are also mentioned.
Molecular docking is a computer modeling technique used to predict the preferred orientation of one molecule to another when bound to form a stable complex. It involves fitting potential drug molecules into the active site of a protein receptor in order to identify which molecules may bind strongly. There are different approaches to molecular docking including rigid docking which treats molecules as rigid bodies, and flexible docking which accounts for conformational changes in ligands. The goal of docking is to find binding orientations that minimize the total energy of the system and maximize intermolecular interactions in order to predict effective drug candidates.
molecular docking its types and de novo drug design and application and softw...GAUTAM KHUNE
This ppt deals with all the aspects related to molecular docking ,its types(rigid ,flexible and manual) and screening based on it and also deals with de novo drug design , various softwares available for docking methodologies and applications for molecular docking in new drug design
Cadd and molecular modeling for M.PharmShikha Popali
THE CADD IS FOR THE DRUG DEVELOPMENT THE DIFFERENT STRATEGIES ARE MENTIONED LIKE QSAR MOLECULAR DOCKING, THE DIFFERENT DIMNSIONAL FORMS OF QSAR , THE ADVANCE SAR of it.
Superimposition method- ligand based drug designIshpreet Sachdev
superimposition or alignment methods used in the ligand based drug designing approach.classification of superimposition Rigid alignment method semiflexible alignment method and flexible method. application of superimposition method in pharmacoinformatics or bioinformatics
Structure based drug design- kiranmayiKiranmayiKnv
This presentation helps in detail learning about the structure based drug design. It includes types of structure based drug design and detailed study of docking, de novo drug design.
Molecular docking is the process of placing molecules in configurations to interact with a receptor. There are two main types - rigid docking treats the receptor and ligand as rigid, while flexible docking allows rotation of one molecule. The key stages of molecular docking are receptor and ligand preparation, docking, and evaluation to identify ligands that bind well and predict binding affinity.
This document describes molecular docking of ligands to the anaplastic lymphoma kinase protein using Autodock Tools. It discusses docking methodology including scoring functions, genetic algorithms, and the Autodock software. The document then outlines the steps taken to dock four ligands (loratinib, ceritinib, crizotinib, alectinib) to the protein, including preparing files and running Autodock. It analyzes and compares the binding energies of the different ligand-protein complexes and visualizes the results, finding that loratinib had the strongest binding to the protein.
Computational drug design uses computer-aided drug design (CADD) approaches like structure-based drug design, ligand-based drug design, and protein-ligand docking to rationally design new drug candidates. These CADD approaches leverage information about protein and ligand structures to predict how well potential drug molecules may bind to their target without relying on experimental screening. Key techniques include pharmacophore modeling, virtual screening, and predicting the binding pose and affinity of ligands docked in the target protein's active site. Accurate preparation of the protein structure is important for successful structure-based drug design applications like protein-ligand docking.
3D QSAR techniques like CoMFA and CoMSIA can quantitatively correlate the biological activity of a series of compounds to their 3D molecular properties. CoMFA generates 3D interaction fields around aligned molecules using steric and electrostatic probes, while CoMSIA additionally considers hydrophobic and hydrogen bonding interactions. The document discusses these techniques and provides an example case study applying CoMFA to develop a QSAR model for human eosinophil phosphodiesterase inhibitors with a cross-validated R2 of 0.565. In conclusion, 3D QSAR is a valuable tool for understanding structure-activity relationships and aiding drug design and discovery efforts.
Structure based computer aided drug designThanh Truong
The document discusses structure-based computer-aided drug design. It describes the drug discovery process and challenges involved in predicting how small molecules bind to protein targets. Key steps in molecular docking include describing the receptor and ligand, sampling possible binding configurations, and scoring the interactions to estimate binding affinity. Genetic and simulated annealing algorithms are commonly used to sample configurations. The accuracy of docking depends on factors like receptor and ligand flexibility.
The document discusses docking, which predicts the optimal binding configuration between two molecules by optimizing their orientation and interaction energy. It describes protein-protein docking where both molecules are rigid, and protein-ligand docking where the ligand is flexible but the protein is rigid. It also discusses the AutoDock software, which uses grids and heuristic search algorithms like genetic algorithms to model docking. It provides examples of docking interleukin-10 to an alkaloid ligand, and nuclear factor kappa-B to a ligand. The document advises considering compounds with binding energies close to or better than a positive control as potential hits.
Lecture 10 pharmacophore modeling and sar paradoxRAJAN ROLTA
The document discusses pharmacophore modeling, which involves identifying the 3D arrangement of functional groups necessary for a molecule to bind to a target site and trigger a biological response. It notes that pharmacophore modeling is important for understanding receptor-ligand interactions and for drug design. Two types are described: ligand-based, which extracts common chemical features from known ligands in the absence of the target structure, and structure-based, which generates features from the target or target-ligand complex structure. Pharmacophore models can be used for virtual screening to identify molecules that encode the required interaction pattern. The document also discusses the structure-activity relationship and notes that similar molecules do not always have similar activities, known as the SAR paradox.
Docking is a method that predicts the preferred orientation of one molecule binding to another to form a stable complex with minimum energy. It is important for rational drug design, as the results can be used to design inhibitors for target proteins and new drugs. Docking is key to structure-based drug design for lead generation and optimization. Factors like intramolecular and intermolecular forces influence docking. There are rigid and flexible docking methods. Molecular docking has been successfully used in drug discovery for HIV, influenza, and other diseases.
Ligand based drug design relies on knowledge of molecules that bind to biological targets of interest. Key approaches include molecular fingerprint and structure searches to identify structurally similar molecules, pharmacophore modeling to describe common physicochemical properties responsible for binding, and QSAR to quantify relationships between biological activity and measurable molecular properties. QSAR uses descriptors like molecular weight, logP, and charge to develop mathematical models that can predict activity of new compounds. Proper data processing is important for building reliable QSAR models. These ligand based techniques provide predictive models for lead identification and optimization in drug design.
This document provides an overview of pharmacophore mapping and pharmacophore-based screening. It defines a pharmacophore as the pattern of molecular features responsible for a drug's biological activity. The key steps in pharmacophore modeling are identifying common binding elements in active compounds, generating potential ligand conformations, and determining the 3D relationships between pharmacophore elements. Pharmacophore models can be generated manually based on known active ligands or automatically using software. Receptor-based pharmacophore generation uses the 3D structure of the target protein to identify favorable binding sites. Overall, pharmacophore mapping is used in computer-aided drug design to identify novel ligands that interact with the same biological target.
THE DRUG DESIGN AND DEVELOPMENT BASED ON DRUG DISCOVERY ,HERE ITS NEED RATIONALE ARE EXPLAINED ALSO QSAR, MOLECULAR DOCKING ITS HISTORY NEED, STRUCTURE BASED DRUG DESIGN IN EASY WAY WE HAVE MENTIONED. THIS WILL MAKE READERS EASY TO COLLECT DATA AT A PLACE ALL OVER THIS IS FOR PHARMA STUDENTS, ACADEMICS, PROFESSIONL AND OST USEFUL FOR RESEARCHERS.
THANK YOU
HOPE YOU WILL LIKE AND SHARE
This document discusses how the Discovery Bus manages the QSAR process by applying different modelling approaches and algorithms to generate many model paths from data in an automated way. It handles tasks like selecting descriptors, splitting data, building models using methods like linear regression and neural networks, and adding results to a database. This allows industrial-scale QSAR to be performed by generating over 750,000 models from 10,000 datasets in 3 weeks using cloud computing resources. The goal of the Discovery Bus is to significantly improve drug discovery productivity by performing the work independently without human involvement.
Docking & Designing Small Molecules within Rosetta Code FrameworkGordon Lemmon
Gordon Howard Lemmon presented his doctoral dissertation on developing methods for docking and designing small molecules within the Rosetta software framework. He summarized structural biology concepts and introduced Rosetta software capabilities for protein modeling, ligand docking, and fragment-based ligand design. Lemmon described improving Rosetta's ability to predict HIV-1 protease and protease inhibitor binding affinities by optimizing score terms and accounting for the unbound state. The new RosettaLigand code allows multiple ligand docking, flexible ligand modeling using fragment rotamers, and fragment-based ligand design. Lemmon concluded that including interface waters can improve docking accuracy, especially in less crowded binding sites.
Molecular docking tools aim to predict the binding mode of ligands to protein receptors. The main tasks are sampling ligand conformations and scoring protein-ligand complexes. Early methods treated proteins and ligands as rigid bodies, while newer methods introduce flexibility. Popular algorithms include Monte Carlo, molecular dynamics, simulated annealing and genetic algorithms. Scoring functions evaluate shape complementarity, empirical potentials, force fields or knowledge-based potentials derived from protein-ligand structures. Consensus scoring integrating multiple functions improves binding affinity prediction over single functions.
In Silico methods for ADMET prediction of new moleculesMadhuraDatar
The document discusses the importance of predicting absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of new molecules in silico during drug design. It describes how ADMET prediction techniques have evolved since 1863 and helped advance drug development. Factors considered in developing ADMET prediction models include the model purpose, required prediction speed and accuracy. Common molecular descriptors used in these models are also discussed. The document outlines methods for predicting various ADMET properties like permeability, solubility, distribution and metabolism in silico. Recent tools for computational ADMET prediction are also mentioned.
Molecular docking is a computer modeling technique used to predict the preferred orientation of one molecule to another when bound to form a stable complex. It involves fitting potential drug molecules into the active site of a protein receptor in order to identify which molecules may bind strongly. There are different approaches to molecular docking including rigid docking which treats molecules as rigid bodies, and flexible docking which accounts for conformational changes in ligands. The goal of docking is to find binding orientations that minimize the total energy of the system and maximize intermolecular interactions in order to predict effective drug candidates.
molecular docking its types and de novo drug design and application and softw...GAUTAM KHUNE
This ppt deals with all the aspects related to molecular docking ,its types(rigid ,flexible and manual) and screening based on it and also deals with de novo drug design , various softwares available for docking methodologies and applications for molecular docking in new drug design
Cadd and molecular modeling for M.PharmShikha Popali
THE CADD IS FOR THE DRUG DEVELOPMENT THE DIFFERENT STRATEGIES ARE MENTIONED LIKE QSAR MOLECULAR DOCKING, THE DIFFERENT DIMNSIONAL FORMS OF QSAR , THE ADVANCE SAR of it.
Superimposition method- ligand based drug designIshpreet Sachdev
superimposition or alignment methods used in the ligand based drug designing approach.classification of superimposition Rigid alignment method semiflexible alignment method and flexible method. application of superimposition method in pharmacoinformatics or bioinformatics
Structure based drug design- kiranmayiKiranmayiKnv
This presentation helps in detail learning about the structure based drug design. It includes types of structure based drug design and detailed study of docking, de novo drug design.
Molecular docking is the process of placing molecules in configurations to interact with a receptor. There are two main types - rigid docking treats the receptor and ligand as rigid, while flexible docking allows rotation of one molecule. The key stages of molecular docking are receptor and ligand preparation, docking, and evaluation to identify ligands that bind well and predict binding affinity.
This document describes molecular docking of ligands to the anaplastic lymphoma kinase protein using Autodock Tools. It discusses docking methodology including scoring functions, genetic algorithms, and the Autodock software. The document then outlines the steps taken to dock four ligands (loratinib, ceritinib, crizotinib, alectinib) to the protein, including preparing files and running Autodock. It analyzes and compares the binding energies of the different ligand-protein complexes and visualizes the results, finding that loratinib had the strongest binding to the protein.
Computational drug design uses computer-aided drug design (CADD) approaches like structure-based drug design, ligand-based drug design, and protein-ligand docking to rationally design new drug candidates. These CADD approaches leverage information about protein and ligand structures to predict how well potential drug molecules may bind to their target without relying on experimental screening. Key techniques include pharmacophore modeling, virtual screening, and predicting the binding pose and affinity of ligands docked in the target protein's active site. Accurate preparation of the protein structure is important for successful structure-based drug design applications like protein-ligand docking.
3D QSAR techniques like CoMFA and CoMSIA can quantitatively correlate the biological activity of a series of compounds to their 3D molecular properties. CoMFA generates 3D interaction fields around aligned molecules using steric and electrostatic probes, while CoMSIA additionally considers hydrophobic and hydrogen bonding interactions. The document discusses these techniques and provides an example case study applying CoMFA to develop a QSAR model for human eosinophil phosphodiesterase inhibitors with a cross-validated R2 of 0.565. In conclusion, 3D QSAR is a valuable tool for understanding structure-activity relationships and aiding drug design and discovery efforts.
Structure based computer aided drug designThanh Truong
The document discusses structure-based computer-aided drug design. It describes the drug discovery process and challenges involved in predicting how small molecules bind to protein targets. Key steps in molecular docking include describing the receptor and ligand, sampling possible binding configurations, and scoring the interactions to estimate binding affinity. Genetic and simulated annealing algorithms are commonly used to sample configurations. The accuracy of docking depends on factors like receptor and ligand flexibility.
The document discusses docking, which predicts the optimal binding configuration between two molecules by optimizing their orientation and interaction energy. It describes protein-protein docking where both molecules are rigid, and protein-ligand docking where the ligand is flexible but the protein is rigid. It also discusses the AutoDock software, which uses grids and heuristic search algorithms like genetic algorithms to model docking. It provides examples of docking interleukin-10 to an alkaloid ligand, and nuclear factor kappa-B to a ligand. The document advises considering compounds with binding energies close to or better than a positive control as potential hits.
Lecture 10 pharmacophore modeling and sar paradoxRAJAN ROLTA
The document discusses pharmacophore modeling, which involves identifying the 3D arrangement of functional groups necessary for a molecule to bind to a target site and trigger a biological response. It notes that pharmacophore modeling is important for understanding receptor-ligand interactions and for drug design. Two types are described: ligand-based, which extracts common chemical features from known ligands in the absence of the target structure, and structure-based, which generates features from the target or target-ligand complex structure. Pharmacophore models can be used for virtual screening to identify molecules that encode the required interaction pattern. The document also discusses the structure-activity relationship and notes that similar molecules do not always have similar activities, known as the SAR paradox.
Docking is a method that predicts the preferred orientation of one molecule binding to another to form a stable complex with minimum energy. It is important for rational drug design, as the results can be used to design inhibitors for target proteins and new drugs. Docking is key to structure-based drug design for lead generation and optimization. Factors like intramolecular and intermolecular forces influence docking. There are rigid and flexible docking methods. Molecular docking has been successfully used in drug discovery for HIV, influenza, and other diseases.
Ligand based drug design relies on knowledge of molecules that bind to biological targets of interest. Key approaches include molecular fingerprint and structure searches to identify structurally similar molecules, pharmacophore modeling to describe common physicochemical properties responsible for binding, and QSAR to quantify relationships between biological activity and measurable molecular properties. QSAR uses descriptors like molecular weight, logP, and charge to develop mathematical models that can predict activity of new compounds. Proper data processing is important for building reliable QSAR models. These ligand based techniques provide predictive models for lead identification and optimization in drug design.
This document provides an overview of pharmacophore mapping and pharmacophore-based screening. It defines a pharmacophore as the pattern of molecular features responsible for a drug's biological activity. The key steps in pharmacophore modeling are identifying common binding elements in active compounds, generating potential ligand conformations, and determining the 3D relationships between pharmacophore elements. Pharmacophore models can be generated manually based on known active ligands or automatically using software. Receptor-based pharmacophore generation uses the 3D structure of the target protein to identify favorable binding sites. Overall, pharmacophore mapping is used in computer-aided drug design to identify novel ligands that interact with the same biological target.
THE DRUG DESIGN AND DEVELOPMENT BASED ON DRUG DISCOVERY ,HERE ITS NEED RATIONALE ARE EXPLAINED ALSO QSAR, MOLECULAR DOCKING ITS HISTORY NEED, STRUCTURE BASED DRUG DESIGN IN EASY WAY WE HAVE MENTIONED. THIS WILL MAKE READERS EASY TO COLLECT DATA AT A PLACE ALL OVER THIS IS FOR PHARMA STUDENTS, ACADEMICS, PROFESSIONL AND OST USEFUL FOR RESEARCHERS.
THANK YOU
HOPE YOU WILL LIKE AND SHARE
This document discusses how the Discovery Bus manages the QSAR process by applying different modelling approaches and algorithms to generate many model paths from data in an automated way. It handles tasks like selecting descriptors, splitting data, building models using methods like linear regression and neural networks, and adding results to a database. This allows industrial-scale QSAR to be performed by generating over 750,000 models from 10,000 datasets in 3 weeks using cloud computing resources. The goal of the Discovery Bus is to significantly improve drug discovery productivity by performing the work independently without human involvement.
Docking & Designing Small Molecules within Rosetta Code FrameworkGordon Lemmon
Gordon Howard Lemmon presented his doctoral dissertation on developing methods for docking and designing small molecules within the Rosetta software framework. He summarized structural biology concepts and introduced Rosetta software capabilities for protein modeling, ligand docking, and fragment-based ligand design. Lemmon described improving Rosetta's ability to predict HIV-1 protease and protease inhibitor binding affinities by optimizing score terms and accounting for the unbound state. The new RosettaLigand code allows multiple ligand docking, flexible ligand modeling using fragment rotamers, and fragment-based ligand design. Lemmon concluded that including interface waters can improve docking accuracy, especially in less crowded binding sites.
Molecular docking tools aim to predict the binding mode of ligands to protein receptors. The main tasks are sampling ligand conformations and scoring protein-ligand complexes. Early methods treated proteins and ligands as rigid bodies, while newer methods introduce flexibility. Popular algorithms include Monte Carlo, molecular dynamics, simulated annealing and genetic algorithms. Scoring functions evaluate shape complementarity, empirical potentials, force fields or knowledge-based potentials derived from protein-ligand structures. Consensus scoring integrating multiple functions improves binding affinity prediction over single functions.
1. The document discusses designing drugs to avoid toxicity. It focuses on common safety risks like toxicity associated with the liver, cardiovascular toxicity, genotoxicity, and idiosyncratic toxicity.
2. It describes the safety window and importance of the therapeutic index. The therapeutic index is the ratio of no observable adverse effect level to the human efficacious exposure level.
3. It examines common structural alerts for toxicity risks, including those associated with the liver. Cytochrome P450 inhibition is discussed as the most common liver toxicity. Alkynes and thiophenes are highlighted as structures that can form reactive intermediates leading to toxicity.
Interaction fingerprint: 1D representation of 3D protein-ligand complexesVladimir Chupakhin
Structural interaction fingerprint1 (IFP) was introduced in order to overcome the shortcomings of the existing scoring functions. IFP represent a binary string that encoding a presence or an absence of interactions of a ligand with amino acids of a protein binding site. It is a convenient way to compare and analyze binding poses of the ligands.
―Study of Ligand Based Virtual Screening Tools in Computer Aided Drug Designi...iosrjce
Insilico potential drug target identification involves chemical compounds for inhibiting or promoting
chemical reactions in living organism computational methods are needed for screening through large database
of these to identify a inhibitor for receptor 0ral Multi-AGC Kinase was employed for docking.We investigated
the detailed pharmacology and antitumour activity of the novel clinical drugs and natural ligand. It is
associated with Oral Multi-AGC kinase protein. The various ZINC analogs on basis of 99%, 95%, 90%
similarity for best docking results with protein for predicting a ZINC analog which can be identified under the
category of becoming a potential drug candidate in future. The best mol dock score were for ZINC analog ZINC
ID 72131268 for Irinotecan is -169.087 kcl/mol, ZINC ID 04166028 for Teniposide is -178.235 kcl/mol, ZINC
ID 30731084 for Topotecan is -166.939 kcl/mol and ZINC ID 00899824 for Curcumin is -141.537 kcl/mol.
The two parameter for toxicity properties i.e. Oral LD50 and Mutagenicity were calculated. Oral LD50 and
Mutagenicity values are found.
Accurate protein-protein docking with rapid calculationMasahito Ohue
This document describes improving protein-protein docking prediction accuracy while maintaining rapid calculation speed. The researchers:
1) Proposed adding a simple hydrophobic interaction model to MEGADOCK's docking score, which previously only considered shape complementarity and electrostatics.
2) The new model averages atomic contact energy values for receptor surface atoms, allowing hydrophobic interactions to be incorporated with one convolution calculation instead of multiple as in other methods.
3) Testing on 176 protein complexes showed the new model achieved similar prediction accuracy to ZDOCK while being over 8 times faster, maintaining MEGADOCK's rapid calculation ability.
27.docking protein-protein and protein-ligandAbhijeet Kadam
This document discusses protein-protein and protein-ligand docking. It begins by defining docking as determining whether two biological molecules interact and finding their lowest energy orientation if so. The document then discusses challenges like the large number of possible conformations and small energy changes. It describes different docking study types and techniques used, including surface representation methods and algorithms like DOCK and RosettaDOCK. Finally, it summarizes a protein-protein docking algorithm and notes current problems in docking relate to limited flexibility handling and scoring function efficiency.
This document provides a short review of clustering techniques for students. It defines clustering and different types of grouping methods such as hard vs soft clustering. It discusses popular clustering algorithms like hierarchical clustering, k-means clustering, and density-based clustering. It also covers cluster validity, usability, preprocessing techniques, meta methods, and visual clustering. Open problems in clustering mentioned include how to identify outlier objects and accelerate classification.
The document provides an overview of protein-ligand docking, which is a computational method used in structure-based drug design to predict how small molecules bind to proteins. It discusses key components of docking software including search algorithms that generate poses of ligands in the binding site and scoring functions that calculate binding affinity scores. The document also touches on uses of docking like virtual screening and pose prediction, as well as considerations like flexible docking and handling protein conformations.
1 -val_gillet_-_ligand-based_and_structure-based_virtual_screeningDeependra Ban
The document discusses ligand-based and structure-based virtual screening techniques. It begins with an introduction to the speaker's background and expertise in chemoinformatics. It then provides an overview of the drug discovery challenge and how virtual screening can help address it. The remainder of the document focuses on explaining different virtual screening methods, including ligand-based approaches like similarity searching, pharmacophore mapping, and machine learning methods, as well as structure-based protein-ligand docking. Limitations of methods are discussed along with ways to improve performance, such as using multiple active structures, data fusion techniques, and accounting for conformational flexibility.
Teaching Adults ANYTHING in 4 Easy StepsSharon Bowman
This document outlines a 4-step process for engaging adult learners:
1. Get them connected by having learners write down facts and goals to connect to prior learning.
2. Show and tell by demonstrating concepts and having learners explain them to each other.
3. Let them do it through activities like teach-backs where learners practice and demonstrate skills.
4. Stand back and applaud by having learners self-assess and commit to applying what they learned.
A new approach to design Matrix metallo proteinase inhibitorsVenu Thatikonda
This document discusses a new computer-aided approach to designing inhibitors for matrix metalloproteinases (MMPs). MMPs play an important role in cancer by promoting invasion and metastasis. The approach involves using virtual screening to evaluate large libraries of compounds and identify potential ligands, docking ligands into the target protein structure to predict binding orientation, and evaluating hit compounds through in vivo experiments. This computer-based drug design approach aims to develop new MMP inhibitor drugs for cancer treatment.
A novel approach to determine side effects and toxicity of new drugs - Invers...Venu Thatikonda
This document describes a novel inverse docking approach to determine potential side effects and toxicity of new drugs. The method involves:
1) Creating a protein cavity database by removing ligands and water from protein structures and representing the remaining surface as spheres.
2) Using programs like CASTp and fpocket to further categorize and characterize cavities.
3) Performing an automated search of the cavity database using the inverse docking program INVDOCK to dock drug molecules into different binding pockets.
4) Scoring the docked poses based on ligand-protein interaction energy and comparing to a statistically-derived threshold. Potential off-targets are identified this way. The document provides an example of inverse docking tamox
This is the slide that Terry. T. Um gave a presentation at Kookmin University in 22 June, 2014. Feel free to share it and please let me know if there is some misconception or something.
(http://t-robotics.blogspot.com)
(http://terryum.io)
This doctoral thesis examines novel biodegradable composite wound dressings with controlled release of antibiotic drugs. The dressings consist of a biodegradable fibrous polyglyconate mesh coated with a porous poly(DL-lactic-co-glycolic acid) matrix containing antibiotics. The matrix is prepared using freeze-drying of inverted emulsions to control its microstructure and drug release properties. In vitro and in vivo studies demonstrate the dressings effectively release antibiotics in a controlled manner, inhibit bacteria, do not induce cytotoxicity, and promote faster wound healing in a guinea pig burn injury model compared to conventional dressings. The research contributes to understanding controlled drug release from biomaterials and their application in wound treatment
Six Trumps: Six Learning Principles that Trump Traditional TeachingSharon Bowman
Author: Sharon Bowman. Discover six learning principles from cognitive neuroscience that will dramatically change the ways you teach and the ways your students learn.
The document discusses computer-aided drug design (CADD) and molecular docking techniques. It begins by providing background on the emergence of CADD in the 1980s. It then describes how docking involves computationally sampling ligand conformations in a protein binding site to find an optimized orientation that minimizes free energy. Key components of docking simulations are representation of molecules, conformational searching, and scoring functions to rank results. Rigid docking considers only geometric complementarity while flexible docking accounts for some ligand and protein flexibility using different search algorithms.
This document discusses genomics and proteomics based drug discovery. It explains that genomics involves sequencing genomes to understand gene functions and interactions, while proteomics studies protein expression and interactions. The document outlines how structural bioinformatics and techniques like protein-ligand docking can help in drug target identification and rational drug design. It also discusses how proteomics can aid in various stages of drug discovery like target identification and validation.
In spite of extensive effort by industry and academia to develop new drugs, there are still several diseases that are in need of therapeutic agents and have yet to be developed.
10 years the identification rate of disease-associated targets has been higher than the therapeutics identification rate.
Nevertheless, it is apparent that computational tools provide high hopes that many of the diseases under investigation can be brought under control.
This document discusses various bioinformatics approaches for analyzing molecular interactions, including protein-protein interaction, protein-ligand interaction, docking, pharmacophore, and virtual screening. It provides details on each topic, describing things like how protein-protein interactions occur and are classified, common methods for studying protein-ligand interactions, the basic process and types of docking, and the definition of a pharmacophore. The key topics covered are protein-protein interaction, protein-ligand interaction analysis through methods like docking, and virtual screening using pharmacophore models.
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...bioejjournal
It is reported that Alzheimer disease is linked with hypertension, diabetes type 2 and high cholesterolemia.
The underlying genetic cause relating these diseases are not well studied clinically. But it has been widely
accepted that beta secretase (BACE1) is the main culprit of causing Alzheimer disease. This enzyme comes
under peptidase A1 family. In the present work, ligand based and structure based drug designing have been
reported. QSAR studies were done using 21 gallic acid derivatives dataset to develop good predictive
model in order to predict biological activity and certain descriptors was reported to further enhance the
analgesic activity of gallic acid derivatives. Molecular docking studies were performed in order to find structure based drug design. Two natural gallic acid derivative have been repoted as a potent inhibitor to beta secretase enzyme.
Qsar studies on gallic acid derivatives and molecular docking studies of bace...bioejjournal
It is reported that Alzheimer disease is linked with hypertension, diabetes type 2 and high cholesterolemia. The underlying genetic cause relating these diseases are not well studied clinically. But it has been widely
accepted that beta secretase (BACE1) is the main culprit of causing Alzheimer disease. This enzyme comes under peptidase A1 family. In the present work, ligand based and structure based drug designing have been reported. QSAR studies were done using 21 gallic acid derivatives dataset to develop good predictive
model in order to predict biological activity and certain descriptors was reported to further enhance the
analgesic activity of gallic acid derivatives. Molecular docking studies were performed in order to find
structure based drug design. Two natural gallic acid derivative have been repoted as a potent inhibitor to beta secretase enzyme.
Qsar Studies on Gallic Acid Derivatives and Molecular Docking Studies of Bace...bioejjournal
It is reported that Alzheimer disease is linked with hypertension, diabetes type 2 and high cholesterolemia. The underlying genetic cause relating these diseases are not well studied clinically. But it has been widely accepted that beta secretase (BACE1) is the main culprit of causing Alzheimer disease. This enzyme comes under peptidase A1 family. In the present work, ligand based and structure based drug designing have been
reported. QSAR studies were done using 21 gallic acid derivatives dataset to develop good predictive model in order to predict biological activity and certain descriptors was reported to further enhance the analgesic activity of gallic acid derivatives. Molecular docking studies were performed in order to find
structure based drug design. Two natural gallic acid derivative have been repoted as a potent inhibitor to beta secretase enzyme.
This document discusses structure based drug design. It describes how drug design uses knowledge of biological targets to find new medications. Structure based drug design uses information about the 3D structure of protein targets to design ligands that bind to them. The main methods described are ligand-based drug design through database searching, and receptor-based drug design which builds ligands for a receptor. Molecular docking is also discussed as a key technique to predict how ligands bind to protein targets and identify potential drug candidates.
Computer aided drug design uses computational approaches to aid in the drug discovery process. There are several key approaches including ligand based approaches which identify characteristics of known active ligands, target based approaches which use information about the biological target, and structure based drug design which utilizes 3D structural information. The main steps in drug design include target identification and validation, lead identification and optimization, and preclinical and clinical trials. Computational tools are used throughout the process for tasks like molecular docking, ADMET prediction, and structure activity relationship analysis.
Criterion based Two Dimensional Protein Folding Using Extended GA IJCSEIT Journal
In the dynamite field of biological and protein research, the protein fold recognition for long pattern
protein sequences is a great confrontation for many years. With that consideration, this paper contributes
to the protein folding research field and presents a novel procedure for mapping appropriate protein
structure to its correct 2D fold by a concrete model using swarm intelligence. Moreover, the model
incorporates Extended Genetic Algorithm (EGA) with concealed Markov model (CMM) for effectively
folding the protein sequences that are having long chain lengths. The protein sequences are preprocessed,
classified and then, analyzed with some parameters (criterion) such as fitness, similarity and sequence gaps
for optimal formation of protein structures. Fitness correlation is evaluated for the determination of
bonding strength of molecules, thereby involves in efficient fold recognition task. Experimental results have
shown that the proposed method is more adept in 2D protein folding and outperforms the existing
algorithms.
Computer Added Drug Design is one of the latest technology of medicine world. This short slide will help you to know a little about CADD.If you want to know a vast plz go throw the reference book.
This document discusses pharmacophore approach in rational drug design. It begins by defining a pharmacophore as an abstract description of molecular features necessary for molecular recognition by a biological macromolecule. It then discusses pharmacophore mapping, methods of pharmacophore screening, and applications. Key steps in developing a pharmacophore model include selecting a training set of ligands, conformational analysis, molecular superposition, abstraction, and validation. Pharmacophore models can be used to retrieve potential drug leads from databases and design new molecules.
nternational Journal of Engineering Research and Development is an international premier peer reviewed open access engineering and technology journal promoting the discovery, innovation, advancement and dissemination of basic and transitional knowledge in engineering, technology and related disciplines.
Pharmacophore Modeling and Docking Techniques.pptDrVivekChauhan1
Pharmacophore modeling and molecular docking techniques are important computational methods used in drug design and discovery. Pharmacophore models identify the essential molecular features responsible for biological activity. Molecular docking predicts how drug molecules bind to protein targets. The document discusses key concepts like pharmacophores, bioisosterism, and molecular docking workflows. It also covers common docking software and factors that influence docking results like intramolecular forces and target preparation. Overall, the document provides an overview of pharmacophore modeling and molecular docking techniques that are widely applied in rational drug design.
(Kartik Tiwari) Denovo Drug Design.pptxKartik Tiwari
Hygia Institute of Pharmaceutical Education and Research provides information on drug design. There are two main types of drug design: ligand-based which relies on existing molecules that bind to the target, and structure-based which relies on the 3D structure of the target. De-novo drug design uses the 3D structure of the receptor to design new molecules and involves optimizing ligands to fit the receptor's active site properties. LUDI software aids de-novo design through identifying interaction sites in the receptor, fitting molecular fragments, and linking fragments together to form new drug candidates.
The document describes a computational study aimed at expediting drug discovery by identifying novel protein-protein interaction (PPI) ligands. The study used computational chemistry programs to test ligands against protein structures and identify those that overlay protein secondary structures with a root-mean-square deviation (RMSD) below 0.5 angstroms. Many ligands were found to successfully mimic protein secondary structures with low RMSD values, supporting the hypothesis that novel PPI ligands can be identified in this manner. The results indicate this computational approach may speed up drug discovery by targeting PPIs rather than single protein inhibition.
The document discusses structure-based drug design (SBDD). It first provides background on drug design and SBDD. It then describes some key aspects of SBDD, including using the 3D structure of the biological target obtained from techniques like X-ray crystallography and NMR spectroscopy. It also discusses ligand-based and receptor-based drug design approaches. The document then outlines the typical steps involved in SBDD, including target selection, ligand selection, target preparation, docking, evaluating results, and discusses some molecular docking techniques and scoring functions used to predict binding.
Hey students here i am attaching the powerpoint presenatation on the Receptor/enzyme-interaction and its analysis, Receptor/enzyme cavity size prediction, predicting
the functional components of cavities and the concept regarding the fragment based drug design.
COMPUTATIONAL MODELING OF DRUG DISPOSITION.pptxPoojaArya34
Computational modelling of drug disposition is the integral part of computer aided drug design. different kinds of tools being used in the prediction of drug disposition in human body. This topic in the CADD explains the details about the drug disposition, active transporters and tools.
Historically, drug discovery has focused almost exclusively on efficacy and selectivity against the biological target.
As a result, nearly half of drug candidates fail at phase II and phase III clinical trials because of undesirable drug pharmacokinetics properties, including absorption, distribution, metabolism, excretion, and toxicity (ADMET).
The pressure to control the escalating cost of new drug development has changed the paradigm since the mid-1990s. To reduce the attrition rate at more expensive later stages, in vitroevaluation of ADMET properties in the early phase of drug discovery has been widely adopted.Many high-throughput in vitro ADMET property screening assays have been developed and applied successfully .
For example, Caco-2 and MDCK cell monolayers are widely used to simulate membrane permeability as an in vitro estimation of in vivo absorption.
These in vitro results have enabled the training of in silico models, which could be applied to predict the ADMET properties of compounds even before they are synthesized.
Similar to Determining stable ligand orientation (20)
Your One-Stop Shop for Python Success: Top 10 US Python Development Providersakankshawande
Simplify your search for a reliable Python development partner! This list presents the top 10 trusted US providers offering comprehensive Python development services, ensuring your project's success from conception to completion.
AI-Powered Food Delivery Transforming App Development in Saudi Arabia.pdfTechgropse Pvt.Ltd.
In this blog post, we'll delve into the intersection of AI and app development in Saudi Arabia, focusing on the food delivery sector. We'll explore how AI is revolutionizing the way Saudi consumers order food, how restaurants manage their operations, and how delivery partners navigate the bustling streets of cities like Riyadh, Jeddah, and Dammam. Through real-world case studies, we'll showcase how leading Saudi food delivery apps are leveraging AI to redefine convenience, personalization, and efficiency.
TrustArc Webinar - 2024 Global Privacy SurveyTrustArc
How does your privacy program stack up against your peers? What challenges are privacy teams tackling and prioritizing in 2024?
In the fifth annual Global Privacy Benchmarks Survey, we asked over 1,800 global privacy professionals and business executives to share their perspectives on the current state of privacy inside and outside of their organizations. This year’s report focused on emerging areas of importance for privacy and compliance professionals, including considerations and implications of Artificial Intelligence (AI) technologies, building brand trust, and different approaches for achieving higher privacy competence scores.
See how organizational priorities and strategic approaches to data security and privacy are evolving around the globe.
This webinar will review:
- The top 10 privacy insights from the fifth annual Global Privacy Benchmarks Survey
- The top challenges for privacy leaders, practitioners, and organizations in 2024
- Key themes to consider in developing and maintaining your privacy program
Threats to mobile devices are more prevalent and increasing in scope and complexity. Users of mobile devices desire to take full advantage of the features
available on those devices, but many of the features provide convenience and capability but sacrifice security. This best practices guide outlines steps the users can take to better protect personal devices and information.
Building Production Ready Search Pipelines with Spark and MilvusZilliz
Spark is the widely used ETL tool for processing, indexing and ingesting data to serving stack for search. Milvus is the production-ready open-source vector database. In this talk we will show how to use Spark to process unstructured data to extract vector representations, and push the vectors to Milvus vector database for search serving.
In the rapidly evolving landscape of technologies, XML continues to play a vital role in structuring, storing, and transporting data across diverse systems. The recent advancements in artificial intelligence (AI) present new methodologies for enhancing XML development workflows, introducing efficiency, automation, and intelligent capabilities. This presentation will outline the scope and perspective of utilizing AI in XML development. The potential benefits and the possible pitfalls will be highlighted, providing a balanced view of the subject.
We will explore the capabilities of AI in understanding XML markup languages and autonomously creating structured XML content. Additionally, we will examine the capacity of AI to enrich plain text with appropriate XML markup. Practical examples and methodological guidelines will be provided to elucidate how AI can be effectively prompted to interpret and generate accurate XML markup.
Further emphasis will be placed on the role of AI in developing XSLT, or schemas such as XSD and Schematron. We will address the techniques and strategies adopted to create prompts for generating code, explaining code, or refactoring the code, and the results achieved.
The discussion will extend to how AI can be used to transform XML content. In particular, the focus will be on the use of AI XPath extension functions in XSLT, Schematron, Schematron Quick Fixes, or for XML content refactoring.
The presentation aims to deliver a comprehensive overview of AI usage in XML development, providing attendees with the necessary knowledge to make informed decisions. Whether you’re at the early stages of adopting AI or considering integrating it in advanced XML development, this presentation will cover all levels of expertise.
By highlighting the potential advantages and challenges of integrating AI with XML development tools and languages, the presentation seeks to inspire thoughtful conversation around the future of XML development. We’ll not only delve into the technical aspects of AI-powered XML development but also discuss practical implications and possible future directions.
Driving Business Innovation: Latest Generative AI Advancements & Success StorySafe Software
Are you ready to revolutionize how you handle data? Join us for a webinar where we’ll bring you up to speed with the latest advancements in Generative AI technology and discover how leveraging FME with tools from giants like Google Gemini, Amazon, and Microsoft OpenAI can supercharge your workflow efficiency.
During the hour, we’ll take you through:
Guest Speaker Segment with Hannah Barrington: Dive into the world of dynamic real estate marketing with Hannah, the Marketing Manager at Workspace Group. Hear firsthand how their team generates engaging descriptions for thousands of office units by integrating diverse data sources—from PDF floorplans to web pages—using FME transformers, like OpenAIVisionConnector and AnthropicVisionConnector. This use case will show you how GenAI can streamline content creation for marketing across the board.
Ollama Use Case: Learn how Scenario Specialist Dmitri Bagh has utilized Ollama within FME to input data, create custom models, and enhance security protocols. This segment will include demos to illustrate the full capabilities of FME in AI-driven processes.
Custom AI Models: Discover how to leverage FME to build personalized AI models using your data. Whether it’s populating a model with local data for added security or integrating public AI tools, find out how FME facilitates a versatile and secure approach to AI.
We’ll wrap up with a live Q&A session where you can engage with our experts on your specific use cases, and learn more about optimizing your data workflows with AI.
This webinar is ideal for professionals seeking to harness the power of AI within their data management systems while ensuring high levels of customization and security. Whether you're a novice or an expert, gain actionable insights and strategies to elevate your data processes. Join us to see how FME and AI can revolutionize how you work with data!
Ocean lotus Threat actors project by John Sitima 2024 (1).pptxSitimaJohn
Ocean Lotus cyber threat actors represent a sophisticated, persistent, and politically motivated group that poses a significant risk to organizations and individuals in the Southeast Asian region. Their continuous evolution and adaptability underscore the need for robust cybersecurity measures and international cooperation to identify and mitigate the threats posed by such advanced persistent threat groups.
Things to Consider When Choosing a Website Developer for your Website | FODUUFODUU
Choosing the right website developer is crucial for your business. This article covers essential factors to consider, including experience, portfolio, technical skills, communication, pricing, reputation & reviews, cost and budget considerations and post-launch support. Make an informed decision to ensure your website meets your business goals.
GraphRAG for Life Science to increase LLM accuracyTomaz Bratanic
GraphRAG for life science domain, where you retriever information from biomedical knowledge graphs using LLMs to increase the accuracy and performance of generated answers
Infrastructure Challenges in Scaling RAG with Custom AI modelsZilliz
Building Retrieval-Augmented Generation (RAG) systems with open-source and custom AI models is a complex task. This talk explores the challenges in productionizing RAG systems, including retrieval performance, response synthesis, and evaluation. We’ll discuss how to leverage open-source models like text embeddings, language models, and custom fine-tuned models to enhance RAG performance. Additionally, we’ll cover how BentoML can help orchestrate and scale these AI components efficiently, ensuring seamless deployment and management of RAG systems in the cloud.
Have you ever been confused by the myriad of choices offered by AWS for hosting a website or an API?
Lambda, Elastic Beanstalk, Lightsail, Amplify, S3 (and more!) can each host websites + APIs. But which one should we choose?
Which one is cheapest? Which one is fastest? Which one will scale to meet our needs?
Join me in this session as we dive into each AWS hosting service to determine which one is best for your scenario and explain why!
Unlocking Productivity: Leveraging the Potential of Copilot in Microsoft 365, a presentation by Christoforos Vlachos, Senior Solutions Manager – Modern Workplace, Uni Systems
HCL Notes and Domino License Cost Reduction in the World of DLAUpanagenda
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.
1. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
DOI : 10.5121/ijaia.2015.6508 109
DETERMINING STABLE LIGAND ORIENTATION
USING PARTICLE SWARM OPTIMIZATION
Anupam Ghosh1
Mainak Talukdar2
and Uttam Kumar Roy3
1
Indian Institute of Technology Bombay, Mumbai, India
2
Cognizant Technology Solutions, Kolkata, India
3
Jadavpur University, Kolkata, India
ABSTRACT
Each and every biological function in living organism occurs due to protein-protein interactions. The
diseases are no exception to this. Identifying one or more proteins for a particular disease and then
designing a suitable chemical compound (which is known as drug or ligand) to destroy those proteins is a
challenging topic of research in computational biology. In earlier methods, drugs were designed using only
a few chemical components and were represented as a fixed-length tree. But in reality, a drug contains
many chemical groups collectively known as pharmacophore. Moreover, the chemical length of the drug
cannot be determined before designing that drug.
In the present work, a Particle Swarm Optimization (PSO) based methodology has been proposed to find
out a suitable drug for a particular disease so that the drug-target protein interaction energy becomes
minimum. In the proposed algorithm, the drug is represented as a variable length tree and essential
functional groups are arranged in different positions of that drug. Finally, the structure of the drug is
obtained and its docking energy is minimized simultaneously. Also, the orientation of chemical groups in
the drug is tested so that it can bind to a particular active site of a target protein and the drug fits well
inside the active site of target protein. Here, several inter-molecular forces have been considered for
accuracy of the docking energy. Results are demonstrated for three different target proteins both
numerically and pictorially. Results show that PSO performs better than the earlier methods.
KEYWORDS
Active Site, Docking, Electrostatic Force, Proteins, Van Der Waals Force
1. INTRODUCTION
All over the world major pharmaceutical and biotechnology companies prefer computational
design. The use of computation model for the orientation of structures is done by most of these
companies to reduce their production cost. Protein is a macro molecule primarily consisting of
amino acids [1]. Protein is highly responsible for structural and functional characteristics of cells,
and communication of biological signals among cells. All proteins available in the nature are not
useful for the living organism. However, every biological function in living organism happens as
a result of protein-protein interactions [2, 3]. There are evidences of proteins which cause fatal or
infective diseases. Researchers take keen interest to identify appropriate drug that fits well in the
active sites of harmful protein. These drugs, which can bind in the active site of target protein and
therefore change the functional behavior of that particular protein, are called ligands. This
mechanism of binding of drug with the target protein is called docking [4]. The challenge is to
predict an accurate structure of the ligand when the active site configuration of the target protein
is known.
2. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
110
Docking is very much important in cellular biology. In docking, proteins interact with themselves
and with other molecular components. It is the key concept to oriental drug design. The result of
docking can be used to find inhibitors for specific target proteins and thus to design new stable
drugs. Protein-ligand docking is an energy minimization search and optimization problem with
the aim to find the best ligand conformation for active sites of a target protein.
In this paper, the scope of the well-known Particle Swarm Optimization (PSO) algorithm [5, 2, 6,
7] is studied to determine the ligand structure to be docked at the active site of the target protein.
The choice of PSO in the present context is inspired by social behavior of bird flocking and fish
schooling [8]. It begins with a random population and then searches for optimal solution by
updating the population based on fitness of the current solution.
Evolutionary computation is used to place functional groups in the nodes of the variable tree
structured ligand. The tree structure helps in connecting primitive fragments or radicals to
determine the right candidate solution for the ligand that best suits with the active site of the
protein. The PSO based algorithm flows through the entire search space, and records the best
individuals they have met. At each step, it changes its position according to the best individuals to
reach a new position. In this way, the whole population evolves towards the optimum, step by
step.
A ‘fitness function’ is generally introduced in a meta-heuristics algorithm to determine the quality
of the desired solutions for an optimization problem. Naturally, the better the formulation of the
fitness function, the better is the expected quality of the trial solutions. In the present context of
the ligand-docking problem, optimal selection of the ligand is inspired by minimization of an
energy function that determines the stable connectivity between the protein and the ligand. So, the
fitness function here is an energy function, whose minimization yields trial solutions to the
problem. One important factor in the field of drug design is the identification of proper ligand. In
general, one or more proteins are typically involved in the bio-chemical pathway of a disease. The
treatment aims to appropriately identify those proteins and reduce their effects by designing a
ligand molecule [9] that can bind to protein’s active site. That is, the structure of a ligand
molecule is evolved from a set of groups in close proximity to crucial residues of the protein; a
molecule is thereby designed that fits the protein target receptor such that a criterion for Van Der
Waals & electrostatic interaction energy is optimized. We propose to adopt this approach in this
paper.
In this paper, we propose a novel approach by which the drug is represented by a variable length
tree-like structure, forty-five functional groups, Van Der Waals as well as electrostatics force to
design the ligand structure. We have applied our approach to Human Rhinovirus stain 14,
Plasmodium Falciparum and HIV-1 protease viruses. We have significantly improved the work
done by earlier researchers due to following reasons 1) A new representation for the ligand is
used; 2) Both Van Der Waal and electrostatic energies are optimized and 3) PSO is used because
of its ability to handle to the ligand design problem. It can be seen that PSO method has
performed quite satisfactorily in comparison with Genetic Algorithm (GA) (fixed length tree)
[10], Genetic Algorithm (GA) (Variable length tree)[20], Neighbourhood Based Genetic
Algorithm (NBGA) (fixed length tree) [11], and variable length Neighbourhood Based Genetic
Algorithm (VNBGA) (variable length tree) [12].
The rest of the paper is organized as follows. Section 2 briefs the related work. Section 3 contains
the formulation of protein–ligand docking problem; section 4 depicts the principles used to
predict the ligand structures. In section 5, PSO algorithm used to find the best ligand structure is
described. The pseudo-code for solving the given constrained optimization function is given in
section 6. A comparison of experiment results for 3 proteins in section 7 is also given. Section 8
concludes the paper with the future work.
3. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
111
2. RELATED WORK
A fixed length Genetic Algorithm approach for ligand design was used in [10, 8, 13, 14] to evolve
molecular structure of possible ligand that binds to a given target protein. The drug is represented
by a fixed tree-like structure, comprising of molecules at the nodes and the bonds as links.
Evidently, an a priori knowledge of the size and length of the tree is difficult to obtain before the
experiment.
Another approach for ligand design, which is based on variable length representation of trees on
both sides of the pharmacophore was studied by Bandopadhyay et al [12]. However, the approach
is restricted to build the ligand in two-dimensional space from a small suite of seven functional
groups. Furthermore, the fitness value of the ligand is confined to Van Der Waals force only.
One more approach for ligand design, that is based on the presence of a fixed pharmacophore and
that uses the search capabilities of genetic algorithms, was studied by Goah and Foster [10],
where the harmful protein human Rhinovirus strain14 was used as the target. This pioneering
work assumed a fixed tree structure representation of the molecule on both sides of the
pharmacophore. Evidently, an a priori knowledge of the size of the tree is difficult to obtain.
Moreover, it is known that no unique ligand structure is best for a given active site geometry.
Furthermore, few more algorithms were designed by researchers for ligand design viz. AutoDock
3.05, SODOCK and PSO@AUTODOCK. In [6], a novel optimization algorithm SODOCK is
used for solving protein–ligand docking problems. And results are compared with the
performance of AutoDock 3.05 [15]. SODOCK is based on particle swarm optimization and a
local search strategy. The work uses the environment and energy function of AutoDock 3.05.
Results show that SODOCK performs better than AutoDock in terms of convergence
performance, robustness, and obtained energy.
In [16], a novel meta-heuristic algorithm called PSO@AUTODOCK based on varCPSO and
varCPSO-ls is used to calculate the docking energy. varCPSO stands for velocity adaptive and
regenerative CPSO. varCPSO-ls is varCPSO with local search technique to avoid convergence at
local minima. In addition to that, comparison is done with other docking techniques as GOLD
3.0, DOCK 6.0, FLEXX 2.2.0, AUTODOCK 3.05, and SODOCK. It has been shown that
PSO@AUTODOCK gives highly efficient docking program in terms of speed and quality for
flexible peptide–protein docking and virtual screening studies.
Moreover, a variable length based genetic algorithm was used to predict the design of the drug.
This algorithm yields a possible design of a drug for the target protein of human Rhino virus with
interaction energy of 10.261 Kcal/mol. This energy is less than the energy of interaction obtained
from fixed length GA having interaction energy as 11.452 Kcal/mol.
In our paper, we propose a PSO based approach wherein a variable length tree-like structure,
forty-five functional groups, Van Der Waals and electrostatics force is used to design the ligand
structure. We have compared our PSO based approach with GA (fixed length tree),GA ( variable
length tree) NBGA (fixed length tree) and VNBGA (variable length tree).
3. FORMULATION OF THE PROBLEM
In protein-ligand docking problem, the objective is to minimize the energy. Firstly, the internal
energy of the ligand should be minimized for better stability of the ligand [17]. The inter-
molecular energy value, which is thereafter optimized, is the interaction energy between the
ligand and the active site of the receptor protein. This energy calculation is based on the
proximity of the different residues in the active site of the receptor protein to the closest
4. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
112
functional groups in the ligand and their chemical properties. The inter-molecular interaction
energy is computed in terms of the Van Der Waals energy and the electrostatic energy.
It is noted that the distance between a residue of the target protein receptor and its closest
functional group should be between 0.7
0
A and 2.7
0
A . If the functional group and closest residue
are of different polarity, then electrostatic force of attraction also acts between those molecules.
The interaction energy of the ligand with the protein is the sum of Van Der Waals Force and
electrostatic energy [4].
Eelectrostatics = (1)
Value of
229
0
/10*9
4
1 cmN −=
πε
Where qA
and qB
are the charges of the two atoms is the separation, ε is the dielectric
constant of the surrounding medium r is the distance between charges.
612
r
B
r
A
Evdw
−= (2)
Where A and B are constants and r is distance between the molecules. Value of A and B depends
on the atom pair.
__ Etotal = Eelectrostatics + Evdw ___ (3)
The fitness value is taken as
totalE
F 1=
4. FORMATION OF A LIGAND
In the proposed work, we consider that the ligands are built using the fragments from the suite as
mentioned in Figure 4. Proteins with known active site configuration are used for evolving ligand
structures.
The specific target is the known antiviral binding site of the Human Rhinovirus strain 14,
Plasmodium Falciparum and HIV-1 Protease. The active site of Human Rhinovirus strain 14 is
known as the VP1 barrel as it resembles with a barrel. The molecules which can easily be fit in
the structure having minimum interaction energy will be the evolved drug (i.e. ligand). For
simplification; a 2-dimensional structure is chosen.
In the present context, we represent a ligand as a variable length tree structure. The length of the
ligand will be determined according to the active site of the target protein as it cannot be
determined before finding its structure; this can be seen in Figure 1, Figure 2 and Figure 3.
We have considered the variable length tree having total 15 nodes. These nodes will be filled by
at most 15 functional groups appropriately selected from the set of forty-five functional groups
given in Figure 4.
AB
BA
r
qq
04πε
5. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
113
Figure 3. Active site of HIV-I protease
Figure 2. Active site of Plasmodium Falciparum
Figure 1. Active site of Human Rhinovirus stain 14
6. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
114
Figure 4. A set of forty five groups used to build ligands (45th
group is the NULL group)
5. PARTICLE SWARM OPTIMIZATION ALGORITHM
PSO or Particle Swarm Optimization algorithm is an evolutionary computation technique that
was developed by DT Eberhart and Dr. Kennedy [18]. This algorithm is inspired by social
behavior of bird flocking and fish schooling. It also begins with a random population and
searches for optima by updating the population. In PSO, the potential solutions, called particles,
flow through the whole search space by following the current optimum particles. Each particle
has a speed vector and position vector to represent a possible solution.
PSO uses a simple rule. Before a change, each particle has three choices: (1) insists on oneself (2)
moves towards the optimum it has met (3) moves towards the best the population has met. PSO
reaches to a balanced position among these three choices. The algorithm is described as follows:
)( ,,11,
1
, PPRCVWV
k
di
pBest
di
k
di
k
di
−××+×=
+
)( ,22 PPRC
k
di
gbest
d
−××+ (4)
_____________________ VPP
k
di
k
di
k
di
1
,,
1
,
++
+= ______________________________ (5)
Where V is the velocity, P is the position, k is number of iterations, d is number of particles, i is
number of particle dimensions, W is inertia factor. C1 and C2 are acceleration coefficients. R1 and
R2 are two other constants in the interval (0, 1).
7. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
115
6. SOLVING THE CONSTRAINT OPTIMIZATION PROBLEM USING PSO
Input:
1. Coordinates of active site.
2. Valency and length of 45 functional groups.
Output: Desired ligand structure L for receptor target protein P.
Begin
Call PSO (active_site_P);
End
Procedure PSO (active_site_P)
Begin
1. Initialize each particle Xi with 15 functional groups randomly chosen from the set of 45
groups at Figure 4.
2. Assign initial coordinates to each particle and call calculate energy (Xi ) to find
respective fitness.
3. Calculate fitness of each particle.
4. Calculate velocity and position of PSO parameters.
5. Update pBest and gBest as necessary.
6. Repeat steps 2 to 5 until a convergence criterion is satisfies or maximum iteration ends.
End
7. EXPERIMENTS AND RESULTS
The experiment was carried out in a simulated environment using MATLAB 2011. Population
size for PSO is taken as 50 and the algorithm is run for 100 generation. In each generation, each
of the particles is decoded to obtain the corresponding drug structure. Results are taken for
different possible positions of the drug within the active site, and the evolved drug having the
lowest energy value is taken as the solution. The two dimensional structure of the ligand is drawn
using ChemSketch software [19].
We have applied our proposed PSO based approach on three different proteins viz. Rhino virus
14 Mutant N1105S (1RUC), Plasmodium Falciparum (TS-DHFR) (3DGA) and HIV-1 Protease
(1W5X). Information about these three proteins is obtained from Protein Data Bank
(http://www.rcsb.org/pdb/home/home.do) and the active site of a protein is obtained from
http://dogsite.zbh.uni-hamburg.de/ . Table 1 shows the diseases caused by each of these proteins.
Table1. Protein and corresponding disease caused by the protein.
Name of the protein Disease caused by the protein
Rhino virus 14 Mutant N1105S
(1RUC)
Cough and Cold
Plasmodium Falciparum (TS-DHFR)
(3DGA)
Malaria
HIV-1 Protease
(1W5X)
AIDS
We have compared our PSO based approach using Van Der Waals force with other available
approaches. The docking energy values of the ligand–protein complexes are calculated for
Human Rhinovirus and are given in Table 2. Lower inter-molecular energy values of the ligand
8. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
116
imply better stability of the ligand. As seen in Table 2, our PSO based approach provides more
stable ligands that are associated with lower energy values. Moreover, the length of the ligand is
also checked with the size of active sites. The length of the ligand should always be less than the
length of the active site. In our experiments, it was found that the length of the active site was
8.76
0
A for Human Rhinovirus 14 Mutant N1105S, while the length of the ligand found using
PSO was 8.72
0
A which is less than the length of the active site. Hence, the ligand can fit quite
well inside corresponding active site.
Table 2. Comparison of Result for Human Rhinovirus
Serial
Number
Algorithm
Docking Energy
(Kcal/mol)
1. Fixed length GA
11.6454
2. NBGA (fixed length)
11.5748
3. VNBGA (Variable length)
8.1046
4. Our Proposed Method (Variable length
PSO)
6.5385
Figure 5. Comparison among algorithms mentioned in Table 2.
We have applied Electrostatics force of attraction along with Van Der Waal force to the Human
Rhinovirus; the results obtained are 10.6352 Kcal/mol. However, Van Der Waal force is applied
to Plasmodium Falciparum and HIV-1 Protease and the results obtained are 2.5477 Kcal/mol and
13.4303 Kcal/mol respectively. The application of Electrostatics force along with Van Der Waals
force for Plasmodium Falciparum and HIV-1 Protease will be kept for future work.
The two dimensional structure of ligand molecule evolved using PSO are pictorially represented
in Figure 6, 7 & 8 for Human Rhinovirus strain 14, Plasmodium Falciparum and HIV-1 Protease
respectively. It is clear from the figures that the design molecules using PSO fill up the active
sites quite well.
9. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
117
Figure 7. Generated Ligand Structure for Plasmodium Falciparum
8. CONCLUSION AND FUTURE WORK
We can conclude that the proposed PSO based algorithm primarily optimizes protein-ligand inter-
molecular docking energy. Our algorithm finds the ligand structure in such a way that each ligand
can fit into corresponding active site very well. It also gives better result (less energy) than other
O
NH2
N
H
CH3
O
O
O
NH
O
OH
O
NH2
O
NH2
CH3 N
O
+
O
N
CH3
NH2
N
+
O
+
O
NH
Figure 6. Generated Ligand Structure for Human Rhino Virus
O
OH
NH2
O
O
OH
O
NH2
N
N
O
NH CH3
Figure 8. Generated Ligand Structure for HIV-I Protease
10. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
118
methods. Moreover, using PSO, we can obtain more stable structure of ligand molecule. This
proposed technique can be used to provide a powerful tool for the chemist to evolve molecular
structure of ligand once the functional protein is given.
This work uses a two dimensional approach which has some limitations. A three dimensional
approach using new data structure for the ligand will be our future research goal. Moreover, we
have considered only inter-molecular forces but there are a number of intra-molecular forces like
Bond stretching, angle binding, Dihedral angle. All these forces will give more accurate docking
energy.
REFERENCES
[1] Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., ... & Bourne, P. E.,
(2000) “The protein data bank”, Nucleic acids research,28(1), 235-242.
[2] Reyes, J. A., & Gilbert, D. (2007) “Prediction of protein-protein interactions using one-class
classification methods and integrating diverse data”.
[3] Chatterjee, P., Basu, S., Kundu, M., Nasipuri, M., & Plewczynski, D (2011) “PPI_SVM: Prediction of
protein-protein interactions using machine learning, domain-domain affinities and frequency tables”,
Cellular & molecular biology letters, 16(2), 264-278.
[4] Moitessier, N., Englebienne, P., Lee, D., Lawandi, J., & Corbeil, A. C. (2008) “Towards the
development of universal, fast and highly accurate docking/scoring methods: a long way to go”,
British journal of pharmacology,153(S1), S7-S26.
[5] Engelbrecht, A. P. (2005) “Fundamentals of computational swarm intelligence”, (Vol. 1). Chichester:
Wiley.
[6] Chen, H. M., Liu, B. F., Huang, H. L., Hwang, S. F., & Ho, S. Y. (2007) “SODOCK: swarm
optimization for highly flexible protein–ligand docking”, Journal of computational chemistry, 28(2),
612-623.
[7] Diwold, K., Himmelbach, D., Meier, R., Baldauf, C., & Middendorf, M. (2011) “Bonding as a swarm:
applying bee nest-site selection behaviour to protein docking”, In Proceedings of the 13th annual
conference on Genetic and evolutionary computation (pp. 93-100). ACM.
[8] Eberhart, R. C., & Kennedy, J. (1995) “A new optimizer using particle swarm theory”, In Proceedings
of the sixth international symposium on micro machine and human science (Vol. 1, pp. 39-43).
[9] Andrew R. Leach. (2001) “Molecular modelling: principles and applications”. Pearson Education.
[10] Goha, G. K. M., & Foster, J. A., (2000) “Evolving Molecules for Drug Design Using Genetic
Algorithms”, Proc. Int. Con. On Genetic and Evol. Computing, Morgan Kaufmann, 27-33.
[11] Ghosh, A., Ghosh, A., Chowdhury, A., & Konar, A. (2012) “An Evolutionary Approach to Drug-
Design Using a Novel Neighbourhood Based Genetic Algorithm”, arXiv preprint arXiv:1205.6412.
[12] Bandyopadhyay, S., Bagchi, A., & Maulik, U. (2005) “Active site driven ligand design: An
evolutionary approach”, Journal of bioinformatics and computational biology, 3(05), 1053-1070.
[13] Michalewicz, Z. (1996) “Genetic algorithms+ data structures= evolution programs”, Springer Science
& Business Media.
[14] Syswerda, G. (1991). “A study of reproduction in generational and steady state genetic algorithms”,
Foundations of genetic algorithms, 2, 94-101.
[15] Wei, D., Jiang, X., Zhou, L., Chen, J., Chen, Z., He, C., & Lai, L. (2008) “Discovery of multitarget
inhibitors by combining molecular docking with common pharmacophore matching”, Journal of
medicinal chemistry, 51(24), 7882-7888.
[16] Namasivayam, V., & Günther, R. (2007) “PSO@AUTODOCK: A fast flexible molecular docking
program based on swarm intelligence”, Chemical biology & drug design, 70(6), 475-484.
[17] Guner, O. F. (2000) “Pharmacophore perception, development, and use in drug design”, International
University Line, La Jolla, CA, 29.
[18] Kennedy, J., & Eberhart, R. C. (1997) “A discrete binary version of the particle swarm algorithm”, In
Systems, Man, and Cybernetics, 1997. Computational Cybernetics and Simulation., 1997 IEEE
International Conference on (Vol. 5, pp. 4104-4108). IEEE.
[19] Veit, R., & Gould, C. (2009) “Writing, reading, and research”, Cengage Learning.
[20] Ghosh, A. (2014). Determining Ligand Orientation for a Protein Receptor using Genetic Algorithm
(Doctoral dissertation, JADAVPUR UNIVERSITY).
11. International Journal of Artificial Intelligence & Applications (IJAIA) Vol. 6, No. 5, September 2015
119
Authors
Uttam K. Roy is presently Assistant Professor in the Department of Information
Technology, Jadavpur University, Kolkata. He completed his M. Tech in Computer
Science and Engineering, and PhD from Jadavpur University, Kolkata. For excellence in
academics, he was awarded scholarships from UGC and Jadavpur University. In addition
to his 12-year teaching experience, he has been a technical consultant and system
administrator.
Dr Roy's research interests include bio-informatics, voice processing, optimization, and quantum
computing. He is the sole author of two text books "Web Technologies" and "Advanced Java
Programming", published by Oxford University Press, India in 2010. He also has contributed numerous
research papers to various international journals, and has guided and supervised many postgraduate and Ph
D dissertations.
Mainak Talukdar is presently working as a Programmer Analyst Trainee at Cognizant
Technology Solutions, Kolkata. He has done Master of Engineering in Software
Engineering from Jadavpur University. Earlier, he has done his Bachelor of Technology in
Computer Science and Engineering from West Bengal University of Technology, Kolkata.
He has about two year of industry experience.
Mainak’s research interests include bio-informatics, data warehousing.
Anupam Ghosh is presently working as a Research Engineer at the Center for Indian
Language Technology, Department of Computer Science and Engineering, Indian Institute
of Technology Bombay, Mumbai. He completed his Master of Engineering from Jadavpur
University, Kolkata. Earlier, He has done his Bachelor of Technology in Computer Science
and Engineering from West Bengal University of Technology, Kolkata. He has Academic
experience of about 2 years and Industry experience of about 2 year.
Anupam’s research interests include bio-informatics, Natural Language Processing. He wishes to pursue
his career in the field of Natural Language Process and Machine Leaning.